nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—Gastric irritation—Liotrix—hypothyroidism	0.0469	0.116	CcSEcCtD
Orphenadrine—Epigastric discomfort—Liotrix—hypothyroidism	0.0346	0.0857	CcSEcCtD
Orphenadrine—GRIN2D—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0207	0.0619	CbGpPWpGaD
Orphenadrine—GRIN2D—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0207	0.0619	CbGpPWpGaD
Orphenadrine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0189	0.0567	CbGpPWpGaD
Orphenadrine—SCN10A—nerve—hypothyroidism	0.018	0.0686	CbGeAlD
Orphenadrine—Tachycardia—Liothyronine—hypothyroidism	0.0175	0.0434	CcSEcCtD
Orphenadrine—GRIN3B—testis—hypothyroidism	0.0174	0.0662	CbGeAlD
Orphenadrine—GRIN1—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0148	0.0444	CbGpPWpGaD
Orphenadrine—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0148	0.0444	CbGpPWpGaD
Orphenadrine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0136	0.0406	CbGpPWpGaD
Orphenadrine—GRIN2D—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.0135	0.0404	CbGpPWpGaD
Orphenadrine—CYP2E1—urine—hypothyroidism	0.0112	0.0428	CbGeAlD
Orphenadrine—SLC6A2—nerve—hypothyroidism	0.0112	0.0427	CbGeAlD
Orphenadrine—KCNH2—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.0111	0.0334	CbGpPWpGaD
Orphenadrine—GRIN2D—Post NMDA receptor activation events—NEFL—hypothyroidism	0.0111	0.0332	CbGpPWpGaD
Orphenadrine—Tension—Levothyroxine—hypothyroidism	0.0106	0.0263	CcSEcCtD
Orphenadrine—Tension—Dextrothyroxine—hypothyroidism	0.0106	0.0263	CcSEcCtD
Orphenadrine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.0102	0.0306	CbGpPWpGaD
Orphenadrine—Tremor—Dextrothyroxine—hypothyroidism	0.0101	0.0251	CcSEcCtD
Orphenadrine—Tremor—Levothyroxine—hypothyroidism	0.0101	0.0251	CcSEcCtD
Orphenadrine—Agitation—Levothyroxine—hypothyroidism	0.00993	0.0246	CcSEcCtD
Orphenadrine—Agitation—Dextrothyroxine—hypothyroidism	0.00993	0.0246	CcSEcCtD
Orphenadrine—GRIN1—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00967	0.0289	CbGpPWpGaD
Orphenadrine—Palpitations—Levothyroxine—hypothyroidism	0.00955	0.0237	CcSEcCtD
Orphenadrine—Palpitations—Dextrothyroxine—hypothyroidism	0.00955	0.0237	CcSEcCtD
Orphenadrine—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00942	0.0282	CbGpPWpGaD
Orphenadrine—CYP3A4—urine—hypothyroidism	0.00903	0.0344	CbGeAlD
Orphenadrine—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00894	0.0268	CbGpPWpGaD
Orphenadrine—Confusional state—Levothyroxine—hypothyroidism	0.00889	0.022	CcSEcCtD
Orphenadrine—Confusional state—Dextrothyroxine—hypothyroidism	0.00889	0.022	CcSEcCtD
Orphenadrine—Tachycardia—Levothyroxine—hypothyroidism	0.0086	0.0213	CcSEcCtD
Orphenadrine—Tachycardia—Dextrothyroxine—hypothyroidism	0.0086	0.0213	CcSEcCtD
Orphenadrine—GRIN1—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00795	0.0238	CbGpPWpGaD
Orphenadrine—SCN4A—heart—hypothyroidism	0.00783	0.0298	CbGeAlD
Orphenadrine—Tension—Liotrix—hypothyroidism	0.0078	0.0193	CcSEcCtD
Orphenadrine—GRIN2D—testis—hypothyroidism	0.00776	0.0296	CbGeAlD
Orphenadrine—Vision blurred—Liotrix—hypothyroidism	0.00749	0.0186	CcSEcCtD
Orphenadrine—Tremor—Liotrix—hypothyroidism	0.00744	0.0184	CcSEcCtD
Orphenadrine—SCN9A—pituitary gland—hypothyroidism	0.00733	0.028	CbGeAlD
Orphenadrine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00733	0.0219	CbGpPWpGaD
Orphenadrine—Agitation—Liotrix—hypothyroidism	0.0073	0.0181	CcSEcCtD
Orphenadrine—GRIN3A—testis—hypothyroidism	0.0073	0.0278	CbGeAlD
Orphenadrine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00727	0.018	CcSEcCtD
Orphenadrine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00727	0.018	CcSEcCtD
Orphenadrine—GRIN2D—cerebellum—hypothyroidism	0.00717	0.0273	CbGeAlD
Orphenadrine—Palpitations—Liotrix—hypothyroidism	0.00702	0.0174	CcSEcCtD
Orphenadrine—Urticaria—Levothyroxine—hypothyroidism	0.007	0.0174	CcSEcCtD
Orphenadrine—Urticaria—Dextrothyroxine—hypothyroidism	0.007	0.0174	CcSEcCtD
Orphenadrine—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00696	0.0208	CbGpPWpGaD
Orphenadrine—SCN9A—adrenal gland—hypothyroidism	0.00655	0.025	CbGeAlD
Orphenadrine—SCN4A—pituitary gland—hypothyroidism	0.00654	0.0249	CbGeAlD
Orphenadrine—Confusional state—Liotrix—hypothyroidism	0.00654	0.0162	CcSEcCtD
Orphenadrine—Anaphylactic shock—Liotrix—hypothyroidism	0.00649	0.0161	CcSEcCtD
Orphenadrine—GRIN1—cerebellum—hypothyroidism	0.00639	0.0243	CbGeAlD
Orphenadrine—Tachycardia—Liotrix—hypothyroidism	0.00633	0.0157	CcSEcCtD
Orphenadrine—Asthenia—Dextrothyroxine—hypothyroidism	0.00633	0.0157	CcSEcCtD
Orphenadrine—Asthenia—Levothyroxine—hypothyroidism	0.00633	0.0157	CcSEcCtD
Orphenadrine—Pruritus—Levothyroxine—hypothyroidism	0.00624	0.0155	CcSEcCtD
Orphenadrine—Pruritus—Dextrothyroxine—hypothyroidism	0.00624	0.0155	CcSEcCtD
Orphenadrine—SCN5A—heart—hypothyroidism	0.00607	0.0231	CbGeAlD
Orphenadrine—SCN4A—adrenal gland—hypothyroidism	0.00585	0.0223	CbGeAlD
Orphenadrine—SCN5A—cardiovascular system—hypothyroidism	0.00573	0.0218	CbGeAlD
Orphenadrine—SCN4A—thyroid gland—hypothyroidism	0.00564	0.0215	CbGeAlD
Orphenadrine—Vomiting—Levothyroxine—hypothyroidism	0.00561	0.0139	CcSEcCtD
Orphenadrine—Vomiting—Dextrothyroxine—hypothyroidism	0.00561	0.0139	CcSEcCtD
Orphenadrine—SCN10A—pituitary gland—hypothyroidism	0.00558	0.0213	CbGeAlD
Orphenadrine—Constipation—Liotrix—hypothyroidism	0.00555	0.0137	CcSEcCtD
Orphenadrine—Headache—Dextrothyroxine—hypothyroidism	0.00552	0.0137	CcSEcCtD
Orphenadrine—Headache—Levothyroxine—hypothyroidism	0.00552	0.0137	CcSEcCtD
Orphenadrine—SCN9A—testis—hypothyroidism	0.00542	0.0207	CbGeAlD
Orphenadrine—Feeling abnormal—Liotrix—hypothyroidism	0.00534	0.0132	CcSEcCtD
Orphenadrine—Nausea—Dextrothyroxine—hypothyroidism	0.00524	0.013	CcSEcCtD
Orphenadrine—Nausea—Levothyroxine—hypothyroidism	0.00524	0.013	CcSEcCtD
Orphenadrine—CHRM2—heart—hypothyroidism	0.00517	0.0197	CbGeAlD
Orphenadrine—Urticaria—Liotrix—hypothyroidism	0.00515	0.0128	CcSEcCtD
Orphenadrine—SCN10A—blood—hypothyroidism	0.00499	0.019	CbGeAlD
Orphenadrine—CHRM2—cardiovascular system—hypothyroidism	0.00488	0.0186	CbGeAlD
Orphenadrine—SCN4A—testis—hypothyroidism	0.00483	0.0184	CbGeAlD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00479	0.0143	CbGpPWpGaD
Orphenadrine—Hypersensitivity—Liotrix—hypothyroidism	0.00478	0.0118	CcSEcCtD
Orphenadrine—Asthenia—Liotrix—hypothyroidism	0.00465	0.0115	CcSEcCtD
Orphenadrine—Pruritus—Liotrix—hypothyroidism	0.00459	0.0114	CcSEcCtD
Orphenadrine—SCN5A—blood—hypothyroidism	0.00453	0.0173	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00447	0.0134	CbGpPWpGaD
Orphenadrine—SCN1A—cerebellum—hypothyroidism	0.00431	0.0164	CbGeAlD
Orphenadrine—Dizziness—Liotrix—hypothyroidism	0.00429	0.0106	CcSEcCtD
Orphenadrine—Vomiting—Liotrix—hypothyroidism	0.00412	0.0102	CcSEcCtD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00412	0.0123	CbGpPWpGaD
Orphenadrine—Headache—Liotrix—hypothyroidism	0.00406	0.0101	CcSEcCtD
Orphenadrine—GRIN1—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00406	0.0121	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00399	0.0119	CbGpPWpGaD
Orphenadrine—Nausea—Liotrix—hypothyroidism	0.00385	0.00955	CcSEcCtD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00383	0.0115	CbGpPWpGaD
Orphenadrine—KCNH2—heart—hypothyroidism	0.00373	0.0142	CbGeAlD
Orphenadrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00368	0.011	CbGpPWpGaD
Orphenadrine—SLC6A2—gonad—hypothyroidism	0.00356	0.0136	CbGeAlD
Orphenadrine—KCNH2—cardiovascular system—hypothyroidism	0.00352	0.0134	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—SLC5A7—hypothyroidism	0.00342	0.0102	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0032	0.00958	CbGpPWpGaD
Orphenadrine—CYP2B6—adrenal cortex—hypothyroidism	0.00317	0.0121	CbGeAlD
Orphenadrine—KCNH2—pituitary gland—hypothyroidism	0.00312	0.0119	CbGeAlD
Orphenadrine—SLC6A2—adrenal gland—hypothyroidism	0.0031	0.0118	CbGeAlD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00309	0.00924	CbGpPWpGaD
Orphenadrine—CYP2B6—heart—hypothyroidism	0.00307	0.0117	CbGeAlD
Orphenadrine—CYP2B6—cardiovascular system—hypothyroidism	0.00289	0.011	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00288	0.00862	CbGpPWpGaD
Orphenadrine—KCNH2—adrenal gland—hypothyroidism	0.00279	0.0106	CbGeAlD
Orphenadrine—KCNH2—blood—hypothyroidism	0.00279	0.0106	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00274	0.00821	CbGpPWpGaD
Orphenadrine—CYP2E1—cardiovascular system—hypothyroidism	0.00271	0.0103	CbGeAlD
Orphenadrine—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00265	0.00795	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00265	0.00794	CbGpPWpGaD
Orphenadrine—CYP2B6—gonad—hypothyroidism	0.00263	0.01	CbGeAlD
Orphenadrine—KCNH2—female gonad—hypothyroidism	0.0026	0.00991	CbGeAlD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00257	0.0077	CbGpPWpGaD
Orphenadrine—SLC6A2—testis—hypothyroidism	0.00257	0.00978	CbGeAlD
Orphenadrine—GRIN1—Neuronal System—SLC5A7—hypothyroidism	0.00245	0.00734	CbGpPWpGaD
Orphenadrine—KCNH2—testis—hypothyroidism	0.00231	0.00879	CbGeAlD
Orphenadrine—CYP2B6—adrenal gland—hypothyroidism	0.00229	0.00872	CbGeAlD
Orphenadrine—CYP2B6—blood—hypothyroidism	0.00229	0.00872	CbGeAlD
Orphenadrine—HRH1—adrenal gland—hypothyroidism	0.00223	0.00851	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—NEFL—hypothyroidism	0.00221	0.0066	CbGpPWpGaD
Orphenadrine—CYP2E1—adrenal gland—hypothyroidism	0.00215	0.00818	CbGeAlD
Orphenadrine—CYP2E1—blood—hypothyroidism	0.00215	0.00818	CbGeAlD
Orphenadrine—KCNH2—cerebellum—hypothyroidism	0.00213	0.00811	CbGeAlD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00212	0.00635	CbGpPWpGaD
Orphenadrine—HRH1—female gonad—hypothyroidism	0.00208	0.00794	CbGeAlD
Orphenadrine—SCN9A—Axon guidance—CLTC—hypothyroidism	0.00208	0.00623	CbGpPWpGaD
Orphenadrine—CYP2E1—thyroid gland—hypothyroidism	0.00207	0.0079	CbGeAlD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00206	0.00617	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SLC5A7—hypothyroidism	0.00204	0.00611	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00191	0.00572	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—CLTC—hypothyroidism	0.00191	0.00572	CbGpPWpGaD
Orphenadrine—CYP2B6—testis—hypothyroidism	0.00189	0.00721	CbGeAlD
Orphenadrine—HRH1—testis—hypothyroidism	0.00185	0.00704	CbGeAlD
Orphenadrine—SCN10A—Axon guidance—CLTC—hypothyroidism	0.00184	0.00552	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—CLTC—hypothyroidism	0.00184	0.00552	CbGpPWpGaD
Orphenadrine—CYP2B6—liver—hypothyroidism	0.00179	0.00682	CbGeAlD
Orphenadrine—CYP2E1—testis—hypothyroidism	0.00178	0.00677	CbGeAlD
Orphenadrine—CYP3A4—blood—hypothyroidism	0.00173	0.00658	CbGeAlD
Orphenadrine—CYP2E1—liver—hypothyroidism	0.00168	0.0064	CbGeAlD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00167	0.00501	CbGpPWpGaD
Orphenadrine—CYP2E1—cerebellum—hypothyroidism	0.00164	0.00625	CbGeAlD
Orphenadrine—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.0016	0.00479	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—NEFL—hypothyroidism	0.00158	0.00473	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—CLTC—hypothyroidism	0.00151	0.00451	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CLTC—hypothyroidism	0.00148	0.00444	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00139	0.00415	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00137	0.00409	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CLTC—hypothyroidism	0.00136	0.00408	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—VAV3—hypothyroidism	0.00136	0.00407	CbGpPWpGaD
Orphenadrine—CYP3A4—liver—hypothyroidism	0.00135	0.00515	CbGeAlD
Orphenadrine—KCNH2—Neuronal System—NEFL—hypothyroidism	0.00132	0.00394	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CLTC—hypothyroidism	0.00132	0.00394	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CLTC—hypothyroidism	0.00132	0.00394	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—CLTC—hypothyroidism	0.0013	0.00388	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00123	0.00368	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CLTC—hypothyroidism	0.00108	0.00322	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.00106	0.00318	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00106	0.00316	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00102	0.00306	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VAV3—hypothyroidism	0.00098	0.00293	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000925	0.00277	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—TRH—hypothyroidism	0.000911	0.00273	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VAV3—hypothyroidism	0.000901	0.0027	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VAV3—hypothyroidism	0.000869	0.0026	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VAV3—hypothyroidism	0.000869	0.0026	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000854	0.00256	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00085	0.00255	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000815	0.00244	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VAV3—hypothyroidism	0.000711	0.00213	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000705	0.00211	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VAV3—hypothyroidism	0.0007	0.00209	CbGpPWpGaD
Orphenadrine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000675	0.00202	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000669	0.002	CbGpPWpGaD
Orphenadrine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000661	0.00198	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VAV3—hypothyroidism	0.000643	0.00192	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VAV3—hypothyroidism	0.00062	0.00186	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VAV3—hypothyroidism	0.00062	0.00186	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000611	0.00183	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000604	0.00181	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000594	0.00178	CbGpPWpGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000547	0.00164	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000545	0.00163	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000538	0.00161	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000538	0.00161	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000536	0.0016	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000529	0.00158	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000529	0.00158	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000527	0.00158	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VAV3—hypothyroidism	0.000507	0.00152	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	0.000479	0.00143	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TRH—hypothyroidism	0.00046	0.00138	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000452	0.00135	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000436	0.0013	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000428	0.00128	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TSHB—hypothyroidism	0.00041	0.00123	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TSHR—hypothyroidism	0.00041	0.00123	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000403	0.00121	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000403	0.00121	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—IYD—hypothyroidism	0.000343	0.00103	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00034	0.00102	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—IYD—hypothyroidism	0.000336	0.00101	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000317	0.000949	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000312	0.000934	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000307	0.000918	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ATP5O—hypothyroidism	0.000292	0.000873	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—POMC—hypothyroidism	0.000291	0.00087	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000286	0.000855	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.000285	0.000853	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TPO—hypothyroidism	0.000274	0.000821	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TPO—hypothyroidism	0.000269	0.000804	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000268	0.000801	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000261	0.000781	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TRH—hypothyroidism	0.00026	0.000778	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000256	0.000765	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000249	0.000745	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—AVP—hypothyroidism	0.000241	0.000723	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000238	0.000711	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TRH—hypothyroidism	0.000236	0.000706	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000232	0.000695	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	0.000232	0.000693	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	0.000232	0.000693	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000228	0.000682	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000228	0.000682	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000211	0.000631	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TSHB—hypothyroidism	0.00021	0.000629	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TSHR—hypothyroidism	0.00021	0.000629	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000207	0.000621	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000207	0.000619	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000207	0.000619	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CLTC—hypothyroidism	0.000161	0.000483	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—POMC—hypothyroidism	0.00016	0.00048	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000159	0.000475	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000158	0.000473	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IYD—hypothyroidism	0.000156	0.000467	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	0.000142	0.000424	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	0.000139	0.000417	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TRH—hypothyroidism	0.000139	0.000417	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TRH—hypothyroidism	0.000137	0.00041	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AVP—hypothyroidism	0.000136	0.000408	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	0.000134	0.000402	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000133	0.000397	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000132	0.000396	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	0.000129	0.000385	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TSHB—hypothyroidism	0.000127	0.00038	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	0.000127	0.000379	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TPO—hypothyroidism	0.000125	0.000373	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TSHB—hypothyroidism	0.000124	0.000372	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSHB—hypothyroidism	0.000124	0.000372	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSHR—hypothyroidism	0.000124	0.000372	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AVP—hypothyroidism	0.000124	0.000371	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSHB—hypothyroidism	0.000122	0.000366	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSHR—hypothyroidism	0.000122	0.000366	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AVP—hypothyroidism	0.000122	0.000365	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	0.000113	0.000339	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	0.000111	0.000332	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	0.000111	0.000331	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	0.000109	0.000326	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC5A5—hypothyroidism	9.5e-05	0.000285	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC5A5—hypothyroidism	9.31e-05	0.000279	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	9.07e-05	0.000271	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	8.92e-05	0.000267	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—hypothyroidism	8.23e-05	0.000246	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRL—hypothyroidism	8.21e-05	0.000246	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—hypothyroidism	8.1e-05	0.000243	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRL—hypothyroidism	8.08e-05	0.000242	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VAV3—hypothyroidism	7.6e-05	0.000227	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VAV3—hypothyroidism	7.48e-05	0.000224	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AVP—hypothyroidism	7.32e-05	0.000219	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AVP—hypothyroidism	7.2e-05	0.000216	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TSHB—hypothyroidism	5.77e-05	0.000173	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	5.14e-05	0.000154	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—hypothyroidism	4.97e-05	0.000149	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—hypothyroidism	4.87e-05	0.000146	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—hypothyroidism	4.86e-05	0.000146	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—hypothyroidism	4.79e-05	0.000143	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—hypothyroidism	4.68e-05	0.00014	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—hypothyroidism	4.6e-05	0.000138	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	4.32e-05	0.000129	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—hypothyroidism	2.26e-05	6.76e-05	CbGpPWpGaD
